论文部分内容阅读
目的探讨微血管减压术治疗原发性三叉神经痛的临床价值。方法回顾性分析35例微血管减压手术治疗的原发性三叉神经痛患者的临床资料,对治疗结果进行分析讨论。结果 35例患者中,34例治愈。无严重并发症,无手术死亡。随访3~12个月,1例复发。结论三叉神经微血管减压术治疗原发性原发性三叉神经痛安全有效,复发率低,三叉神经功能可得到有效保护,可作为原发性三叉神经痛的首选治疗方法。
Objective To investigate the clinical value of microvascular decompression in the treatment of primary trigeminal neuralgia. Methods The clinical data of 35 patients with primary trigeminal neuralgia undergoing microvascular decompression surgery were retrospectively analyzed. The treatment results were analyzed and discussed. Results Of the 35 patients, 34 were cured. No serious complications, no surgical death. Follow-up 3 to 12 months, 1 case of recurrence. Conclusions Trigeminal nerve microvascular decompression is safe and effective in treating primary trigeminal neuralgia. The recurrence rate is low and the function of trigeminal nerve can be effectively protected. It may be the first choice for the treatment of primary trigeminal neuralgia.